| Literature DB >> 32633419 |
Steven X Cho1, Saptha Vijayan2, Ji-Seung Yoo1, Toshiyuki Watanabe1, Ryota Ouda1, Ning An1, Koichi S Kobayashi1,2.
Abstract
The presentation of antigenic peptides by major histocompatibility complex (MHC) class I and class II molecules is crucial for activation of the adaptive immune system. The nucleotide-binding domain and leucine-rich repeat receptor family members CIITA and NLRC5 function as the major transcriptional activators of MHC class II and class I gene expression, respectively. Since the identification of NLRC5 as the master regulator of MHC class I and class-I-related genes, there have been major advances in understanding the function of NLRC5 in infectious diseases and cancer. Here, we discuss the biological significance and mechanism of NLRC5-dependent MHC class I expression.Entities:
Keywords: cancer immune evasion; class I transactivator; major histocompatibility complex class I; regulatory factor X
Mesh:
Substances:
Year: 2020 PMID: 32633419 PMCID: PMC7884647 DOI: 10.1111/imm.13235
Source DB: PubMed Journal: Immunology ISSN: 0019-2805 Impact factor: 7.397